Valyl-tRNA synthetase 2, mitochondrial

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from VARSL)

Valyl-tRNA synthetase 2, mitochondrial or Valine--TRNA Ligase, Mitochondrial or VARS2 or VARS2L or VARSL or DKFZP434L1435 or G7a or KIAA1885 is a protein encoded by the VARS2 gene. VARS2 encodes mitochondrial aminoacyl-tRNA synthetase, which catalyzes the attachment of valine to tRNA(Val) for mitochondrial translation.[1][2]

Function[edit | edit source]

VARS2 gene mutations cause combined oxidative phosphorylation deficiency-20, and are associated with:

  • early-onset mitochondrial encephalopathies
  • neurodevelopmental disorder With microcephaly (unusually small skull will be visible at birth)
  • seizures
  • cortical atrophy (a wasting in part of the brain matter)[1][2]

ME/CFS[edit | edit source]

The ME/CFS Gene Study is still collecting data, but the pilot study publication by Perez et al. (2019) found that VARS2 was one of the ten relatively common genes or gene variants that were both significantly more common in people with ME/CFS, and likely to be harmful.[3]

Notable studies[edit | edit source]

  • 2019, Genetic Predisposition for Immune System, Hormone, and Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Study[3] (Full text)

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 "VARS2 protein expression summary". The Human Protein Atlas. Retrieved January 16, 2022.
  2. 2.0 2.1 "VARS2 Gene". Gene Cards. Retrieved January 16, 2022.
  3. 3.0 3.1 Nathanson, Lubov; Craddock, Travis J.A.; Klimas, Nancy G.; Gemayel, Kristina; Del Alamo, Ana; Hilton, Kelly; Jaundoo, Rajeev; Perez, Melanie (2019). "Genetic Predisposition for Immune System, Hormone, and Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Pilot Study". Frontiers in Pediatrics. 7: 206. doi:10.3389/fped.2019.00206. ISSN 2296-2360.